Medication Adherence and Compliance Uncontrolled variables in psychiatric clinical drug trials According to Griswold, Murray & Corrado (2012), one troubling aspect of psychotropic drug clinical trials is the lack of controls for subjects' adherence to medication protocols. Psychiatric patients in particular have historically been noted to have relatively low levels of compliance. In general, "as drug dosages increase, treatment adherence decrease" because of intensification of symptoms, difficulty remembering dosages, and other issues

Minimizing Risk in a Study One of the biggest challenges in conducting pharmaceutical research are the risks involved. This is because they can increase the potential legal liabilities and have a negative impact on everyone. To address them requires looking at: the circumstance for exclusion / inclusion / the maximum results, who approves the modifications and what can cause a study to end prior to its completion. Together, these different elements

It so happened that Russian doctor Karlov was trying to find patients for another clinical trial for an experimental drug, and Ershov fit the requirements to enter the study. "They told me the treatment was safe," says Ershov. "I trust my doctor completely." Like 90% of Karlov's other clinical-trial patients, he immediately signed the consent form (Lustgarten, p. 1). Russia is one of those countries that suffers from high

14). Soon, Congress passed the Marijuana Tax Act, which was signed into law in 1937. Like the Harrison Act, the Marijuana Tax Act placed marijuana into the same category as the cocaine and opium drugs. It was now illegal to import marijuana into the United States (McWilliams, 1991). However, this law was ineffective in curbing marijuana use (Brecher, 1986, p. 14). By the early 1940s narcotic addiction had significantly reduced

"The increased dopamine flow in the frontal cortex then allows the brain to carry on its executive functions as a normal brain would, thus counteracting the effects of ADHD" (3). Treatment of ADHD: Even for individuals with the illness for whom Adderall is most commonly prescribed, "The effectiveness of ADDERALL® for long-term use has not been systematically evaluated in controlled trials," in a longitudinal fashion and is usually a part of

Some worry that the rights of these individuals are being overlooked, since they while they are 'voluntary' test subjects, they may not be thinking clearly of the consequences, but instead about payments. Manager's Responsibilities Management of Eli Lilly should investigate the test subject's activities after leaving the drug trials. Although the subjects are sober during the tests, if they revert back to drinking, the alcohol could have a negative effect on